Phase 3 study assessing LUMIFY Preservative Free and LUMIFY eye drops meets primary end point

Published on July 29, 2025
The primary objective of the study was to demonstrate that LUMIFY Preservative Free redness reliever eye drops is non-inferior to LUMIFY redness reliever eye drops in reducing ocular redness.
Continue reading on website
Other news

Ziemer USA, CorneaGen launch GALILEI CTAK module for GALILEI diagnostic platform

July 29, 2025
The module can be used in combination with Ziemer’s FEMTO LDV Z8 femtosecond laser platform, an all-in-one laser for refractive, cataract, and therapeutic surgery.

Retinal Detachment Incidence Follows a Seasonal Course

July 30, 2025
Higher numbers of RRD cases in summer could be because of ease of access to the hospital in comparison with winter months, which could present limitations in transportation for patients living in harsher weather conditions. Photo: Mark Dunbar, OD. Click image to enlarge.  Various aspects of physical health wax and wane based on seasonal patterns, but not that many in eye car